WITNESSETHVoting Agreement • November 2nd, 2001 • Essential Therapeutics Inc • Pharmaceutical preparations • Delaware
October 24, 2001 Microcide Pharmaceuticals, Inc. 850 Maude Avenue Mountain View, CA 94043 Attention: Chief Financial Officer Ladies and Gentlemen: Microcide Pharmaceuticals, Inc., a Delaware corporation, (the "Company"), and _____________________ (the...Essential Therapeutics Inc • November 2nd, 2001 • Pharmaceutical preparations
Microcide Pharmaceuticals, Inc., a Delaware corporation, (the "Company"), and _____________________ (the "Investor"), have entered into a Subscription Agreement dated as of July 27, 2001 (the "Subscription Agreement"), providing for the purchase of __________________ shares (the "Shares") of the Company's Series B Convertible Redeemable Preferred Stock ("Company Preferred Stock") by the Investor (the "Investment").
EXHIBIT 3 --------- AGREEMENT --------- Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the...Essential Therapeutics Inc • November 2nd, 2001 • Pharmaceutical preparations
This Schedule 13D was executed by Louis S. Citron pursuant to a Power of Attorney which is being filed with the Securities and Exchange Commission with this Schedule 13D filing for Essential Therapeutics, Inc. and said Power of Attorney is incorporated herein by reference and a copy of which is attached as Exhibit 4.
